文献速递中医内科中药与中成药合理使用

中药调控神经可塑性治疗抑郁症的潜力

The therapeutic potential of traditional Chinese medicine in depression: focused on the modulation of neuroplasticity.
PubMed 文献 · Front Pharmacol · 2024-08-26

抑郁症是全球非致死性健康损失的主要原因,神经可塑性在其发病中起关键作用。本文系统综述了抑郁症中神经可塑性的变化,并分析了中药活性代谢物及复方在抗抑郁治疗中调控神经可塑性的机制,讨论了当前研究的局限与应用前景。

要点

  • 神经可塑性改变参与抑郁症病理过程。
  • 中药活性成分及复方可通过调控神经可塑性发挥抗抑郁作用。
  • 中药调控神经可塑性是抗抑郁研究的重要方向。

核心结论

  • 中药作为补充替代疗法在抑郁症治疗中具有调控神经可塑性的潜力。

研究设计与样本

  • 综述类研究,系统总结近期关于抑郁症神经可塑性变化及中药调控机制的文献。

主要发现

  • 抑郁症伴随神经可塑性改变,中药活性代谢物及复方可调控这些变化。

临床怎么用

  • 可将中药作为抑郁症补充替代治疗的选择之一,关注其神经可塑性调控作用。

局限性

  • 当前研究存在局限性,需进一步探讨中药调控神经可塑性的应用前景。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Depression, a mood disorder characterized by a persistent low mood and lack of enjoyment, is considered the leading cause of non-fatal health losses worldwide. Neuroplasticity refers to the brain's ability to adapt to external or internal stimuli, resulting in functional and structural changes. This process plays a crucial role in the development of depression. Traditional Chinese Medicine (TCM) shows significant potential as a complementary and alternative therapy for neurological diseases, including depression. However, there has been no systematic summary of the role of neuroplasticity in the pathological development of depression and TCM Interventions currently. This review systematically summarized recent literature on changes in neuroplasticity in depression and analyzed the regulatory mechanisms of active metabolites in TCM and TCM formulas on neuroplasticity in antidepressant treatment. Additionally, this review discussed the limitations of current research and the application prospects of TCM in regulating neuroplasticity in antidepressant research.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Lv S, Yang N, Lu Y, et al. The therapeutic potential of traditional Chinese medicine in depression: focused on the modulation of neuroplasticity. Front Pharmacol. 2024. PMID: 39253375. doi:10.3389/fphar.2024.1426769

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。